From the floor in Suzhou: 8 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The archive — 2024
Page 20 of 68 of this archive, newest first.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
What a 32% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
The badge economy, and what it is actually certifying
Every step between the laboratory report and the product page removes information, and the badge is the last step.
SURMOUNT-1 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The 11-day notice: how a compounding wind-down works in the Netherlands
The document is four pages. Three of them are about dates.
The online reseller trading as Adamant Research Supply closes after 19 years
A proper account of an operation that existed, and of what closing it cost.
Australia health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
From cell to clinic: where the extrapolation stops being safe
Receptor pharmacology is strong on average effects and almost silent on individual variation. That gap is where most reader questions live.
Freezing a reconstituted vial: the ice-water interface problem
We set out what is known, what is inferred and what is simply assumed about the fortnight after a vial is opened.
Four millimetres is enough, and the data says so
A 4 mm needle at ninety degrees without a skin pinch is adequate for essentially all adults. The persistence of 12.7 mm needles in this market is habit, not reasoning.
What the nitrogen said
Peptide content is the number that tells you how much drug is in the vial. Almost nobody sells it, almost nobody buys it, and when we paid for it on nine vials the results…
Zhuhai export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
South Korea pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Australia caps exenatide prescribing to 4 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What twenty companies say about storage, and what they have measured
A retest date says that material should be re-examined before use. An expiry date says it should not be used. The trade uses the second word for the first concept.
A guide to the results that will resolve themselves
Three different explanations for the same abnormal number, and how to tell them apart.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
WXT names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a TFC mazdutide lot at 98.4%, against 95.9% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Norway declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
What the trials monitored, and what that implies about routine practice
Timing is the whole of the post-cessation panel: draw it too early and it measures the treatment period.
The tolerability data everybody quotes and nobody reads
Trial adverse-event tables count episodes reported to a study nurse. They are the best data we have and they systematically under-record the mundane.
What a 40% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The consolidator trading as Meridian Freight Partners closes after 6 years
A proper account of an operation that existed, and of what closing it cost.
Quadrupole, time-of-flight, orbital trap: what each class can and cannot see
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
Twelve minutes or forty: what gradient slope buys
A shallow gradient resolves impurities that a steep one runs into the parent peak. Both methods are legitimate; only one of them can see the small stuff.
HJ names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.